6533b85bfe1ef96bd12ba865
RESEARCH PRODUCT
Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
Stefan KasperHarald SchmalenbergG.m. HaagMichael KoenigsmannMichael PohlMarkus MöhlerKim Barbara LuleyMartin SchulerJoerg TrojanPeter C. Thuss-patienceNils HomannThorsten Oliver GoetzeStephan ProbstU. LindigClaudia PauligkG. FolprechtH.-g. KoppR.d. HofheinzElke JaegerS-e. Al-batransubject
0301 basic medicineOncologymedicine.medical_specialtybusiness.industryHematologyOxaliplatin03 medical and health sciences030104 developmental biology0302 clinical medicineGastroesophageal cancerOncologyDocetaxelEsophagogastric cancerFluorouracil030220 oncology & carcinogenesisInternal medicinemedicinebusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2017-09-01 | Annals of Oncology |